C618-0625 Screening compound: N-(4-bromo-2-methylphenyl)-2-{8-methyl-4-oxo-1H,4H-chromeno[4,3-c]pyrazol-1-yl}acetamide

C618-0625 Screening compound: N-(4-bromo-2-methylphenyl)-2-{8-methyl-4-oxo-1H,4H-chromeno[4,3-c]pyrazol-1-yl}acetamide
C618-0625 Screening compound: N-(4-bromo-2-methylphenyl)-2-{8-methyl-4-oxo-1H,4H-chromeno[4,3-c]pyrazol-1-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C618-0625
N-(4-bromo-2-methylphenyl)-2-{8-methyl-4-oxo-1H,4H-chromeno[4,3-c]pyrazol-1-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C618-0625

Molecular Formula

C20H16BrN3O3 (C20 H16 BrN3 O3)

Compound Name

N-(4-bromo-2-methylphenyl)-2-{8-methyl-4-oxo-1H,4H-chromeno[4,3-c]pyrazol-1-yl}acetamide

IUPAC name

N-(4-bromo-2-methylphenyl)-2-{8-methyl-4-oxo-1H4H-chromeno[43-c]pyrazol-1-yl}acetamide

SMILES

Cc(cc1)cc(-c2c3cnn2CC(Nc(cc2)c(C)cc2Br)=O)c1OC3=O

InChI

InChI=1S/C20H16BrN3O3/c1-11-3-6-17-14(7-11)19-15(20(26)27-17)9-22-24(19)10-18(25)23-16-5-4-13(21)8-12(16)2/h3-9H,10H2,1-2H3,(H,23,25)

InChI Key

UCWHRLYNJQWBCI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14777378

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

426.27

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.051

Distribution Coefficient, logD

4.050

Water Solubility, LogSw

-4.07

Polar Surface Area

56.910

Acid Dissociation Constant (pKa)

10.79

Base Dissociation Constant (pKb)

-0.48

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.00

C618-0625 in Drug Discovery

Included in Screening Libraries

BRD4 Targeted Library (4534 compounds)

Protein-Protein Interaction Library (218420 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
  • Immune system
Targets:
  • Others
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C618-0625 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C618-0625?
Check Price and Availability of C618-0625, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C618-0625 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C618-0625
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C618-0625
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C618-0625 available by request